Elbasvir; Grazoprevir Tablet shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting 2025-10-17 · last update 2025-10-17
Manufacturers: Merck Sharp & Dohme LLC
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Zepatier, Tablet, 50 mg; 100 mg (NDC 0006-3074-02) | Merck Sharp & Dohme LLC | To Be Discontinued | — | To be discontinued December 1, 2025 | Posted 10/17/2025 Updated 10/17/2025 Discontinued 10/17/2025 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)